Today's best performers were dominated anew by stocks riding the Artificial Intelligence boom.
Keep Reading →
June 4 - Market Movers, News
On Wednesday, Piper Sandler analyst Matt O’Brien raised the price target on TransMedics Group Inc.
Keep Reading →
June 4 - News
On Wednesday, JPMorgan analyst Doug Anmuth raised the price target for Amazon.com Inc. (NASDAQ:AMZN) to $240 from $225, while maintaining an Overweight rating on the shares.
Keep Reading →
June 4 - News
On Wednesday, UBS raised its price target for BBB Foods Inc. (NYSE:TBBB) from $32 to $33, while maintaining a Neutral rating on the company's shares.
Keep Reading →
June 4 - News
On Wednesday, UBS raised its price target for Ambev (NYSE:ABEV) from $2.60 to $2.70, while maintaining a Neutral rating on the shares.
Keep Reading →
June 4 - News
On Wednesday, Morgan Stanley analyst Sanjit Singh raised the price target for Couchbase Inc.
Keep Reading →
June 4 - News
On Wednesday, Evercore ISI downgraded the rating for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from Outperform to In Line. The price target was also reduced from $450 to $440.
Keep Reading →
June 4 - News
On Wednesday, Cardinal Health Inc. (NYSE:CAH) announced the US launch of its new Kendall DL Multi System.
Keep Reading →
June 4 - News
On June 2, Louisiana-Pacific Corporation (NYSE:LPX) and BlueLinx Holdings Inc. (NYSE:BXC) announced the expansion of their distribution partnership to Springfield, Missouri.
Keep Reading →
June 4 - News
On June 3, BMO Capital’s analyst Rufus Hone reiterated a Buy rating on Corpay Inc. (NYSE:CPAY), with an unchanged price target of $410.
Keep Reading →
June 4 - News
On June 3, Needham analyst Ami Fadia reaffirmed a Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and raised the price target slightly from $200 to $202.
Keep Reading →
June 4 - News
On June 3, BMO Capital Markets analyst Kostas Biliouris reiterated a Hold rating on BridgeBio Pharma Inc. (NASDAQ:BBIO) with an unchanged price target of $37.
Keep Reading →
June 4 - News
On June 3, Jefferies analyst Randal Konik reiterated a Sell rating on Lululemon Athletica Inc. (NASDAQ:LULU) and maintained his price target of $220.
Keep Reading →
June 4 - News
On Wednesday, Needham analyst Laura Martin downgraded Apple Inc. (NASDAQ:AAPL) to Hold from Buy without assigning any price target.
Keep Reading →
June 4 - News
On Wednesday, Chart Industries Inc.
Keep Reading →
June 4 - News
On June 3, Goldman Sachs analyst Atidrip Modak raised the price target on Quanta Services Inc. (NYSE:PWR) from $364 to $414, while maintaining a Buy rating.
Keep Reading →
June 4 - News
On June 3, Bernstein analyst Ian Moore initiated coverage on Spotify Technology S.A. (NYSE:SPOT) with an Outperform rating and assigned a price target of $825.
Keep Reading →
June 4 - News
Wedbush analyst Dan Ives is taking a definitive step to validate his faith in AI. On Wednesday, Wedbush Fund Advisers launched the Dan IVES Wedbush AI Revolution ETF.
Keep Reading →
June 4 - Hedge Funds, Industries, News, Tech
Tina Hou from Goldman Sachs made the price target upgrade after the company’s gross profit and GAAP net profit exceeded Hou's estimates by 6% and 21%, respectively, driven by...
Keep Reading →
June 4 - News
Vijay Rakesh from Mizuho made the update following Nio’s first quarter 2025 results.
Keep Reading →
June 4 - News
The data center is expected to create 1,000 new permanent jobs and nearly 2,000 jobs over the 10-15 year construction process.
Keep Reading →
June 4 - News
Brett Knoblauch from Cantor Fitzgerald noted that the company is gaining market share in the Social Media Management sector.
Keep Reading →
June 4 - News
JPM Analyst, Cory Carpenter, noted that while the company’s shares surged over 50% since its restructuring fiasco, the surge was likely driven by cost cuts rather than sustainable...
Keep Reading →
June 4 - News
From June 4, consumers in the UAE will be able to purchase Pinkglow on the e-commerce platform, Talabat.
Keep Reading →
June 4 - News
UBS analyst John Hodulik increased the price target for NFLX stock, citing the company’s strong viewership and a favorable industry backdrop.
Keep Reading →
June 4 - News
The decision came after Genmab A/S (NASDAQ:GMAB) shared new data on Rina-S in second-line and endometrial cancer treatments at the American Society of Clinical Oncology (ASCO) ...
Keep Reading →
June 4 - News
The reduced price target reflects slightly lower earnings per share (EPS) estimates, mainly due to a lower projection for investment income.
Keep Reading →
June 4 - News
On Tuesday, June 3, Piper Sandler analysts raised the price target on Lululemon Athletica Inc. (NASDAQ:LULU) from $280 to $315 and kept a “Neutral” rating.
Keep Reading →
June 4 - News
The firm’s analysts highlighted NVIDIA Corporation’s (NASDAQ:NVDA) strong potential in the data center sector, especially because of its upcoming large AI infrastructure projects...
Keep Reading →
June 4 - News
Analysts expect this year’s Worldwide Developers Conference (WWDC) by Apple Inc.
Keep Reading →
June 4 - News
During the most recent episode of Mad Money, Jim Cramer opened with a candid admission about the current state of the stock market, expressing frustration at how poorly it’s...
Keep Reading →
June 4 - Hedge Funds, News
On Tuesday’s episode of Mad Money, host Jim Cramer expressed concern over how President Donald Trump's actions have been impacting the stock market as he pointed out the confusion...
Keep Reading →
June 4 - Hedge Funds, News
Mastercard Inc. (NYSE:MA) and PayPal Holdings, Inc. (NASDAQ:PYPL) are collaborating to enhance payment flexibility for shoppers.
Keep Reading →
June 4 - News
Franklin Resources, Inc. (NYSE:BEN) has reiterated its commitment to expanding its global alternative platform and direct lending capabilities across Europe.
Keep Reading →
June 4 - News
On June 3, Truist Securities analysts reiterated a ‘Buy’ rating for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) stock and maintained a $450 price target.
Keep Reading →
June 4 - News
On June 4, analysts at Citi downgraded Constellation Energy Corporation (NASDAQ:CEG) to a ‘Neutral’ from a ‘Buy.’ The downgrade comes after a big rise in the company’...
Keep Reading →
June 4 - News
On June 4, JPMorgan lifted its price target to $6,000 from $5,360 for Booking Holdings Inc. (NASDAQ:BKNG) stock. The firm maintained an ‘Overweight’ rating on the shares.
Keep Reading →
June 4 - News
One of the factors the analysts emphasized as having influenced their decision is Meta’s dominant position in the social media landscape.
Keep Reading →
June 4 - News
On June 4, JPMorgan analysts raised their price target for Duolingo Inc. (NASDAQ:DUOL) from $500 to $580 while keeping an Overweight rating.
Keep Reading →
June 4 - News
On June 3, Citi analysts increased the price target for Western Digital Corporation (NASDAQ:WDC) stock to $62 from $56 while reiterating a 'Buy' rating.
Keep Reading →
June 4 - News
On June 4, JPMorgan analysts increased their price target for Etsy, Inc. (NASDAQ:ETSY) to $50 from $42 while maintaining a ‘Neutral’ rating.
Keep Reading →
June 4 - News
On June 4, UBS upgraded Snowflake Inc. (NYSE:SNOW) stock to a ‘Buy’ from a Neutral and raised the price target to $265 from $210.
Keep Reading →
June 4 - News
RBC Capital has raised its price target on Snowflake Inc.
Keep Reading →
June 4 - News
[caption id="attachment_1230458" align="aligncenter" width="1456"] A leading semiconductor chip on a computer robot arm, reflecting the technology advances of the company.[/caption...
Keep Reading →
June 4 - News
On June 3, analysts at TD Cowen reaffirmed a 'Buy' rating and a $275 price target on Apple Inc. (NASDAQ:AAPL) stock.
Keep Reading →
June 4 - News
On June 3, Cyberwrite, a cyber risk modeling technology provider, said it had expanded its partnership with Markel Group Inc. (NYSE:MKL).
Keep Reading →
June 4 - News
On June 3, analysts at TD Cowen reiterated a Hold rating and a $36 price target on Campbell Soup (NASDAQ:CPB).
Keep Reading →
June 4 - News
On June 3, TD Cowen analysts reiterated a Buy rating on General Motors Company (NYSE:GM) stock and maintained an $83 price target.
Keep Reading →
June 4 - News
Takeda Pharmaceutical Company Limited (NYSE:TAK)'s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized by the European Commission on June 3, 2025, for newly...
Keep Reading →
June 4 - News